Authors



Jerry Wolf, RPh

Latest:

Average Manufacturer Price: Pharmacy Reimbursement Under the Microscope

This expert analysis and rich historical perspective on AMP offers valuable insights into the new AMP Proposed Rule and how it affects specialty pharmacy.



Gordon J. Vanscoy, PharmD, MBA, CACP

Latest:

Specialty Pharmacy Today: Improving the Lives of Patients With Rare Diseases Through Orphan Drug Management

The specialty pharmacy marketplace has quickly become the primary dispenser of most therapies for orphan conditions.


Hannah Lutz, University of Wyoming, PharmD Candidates 2021, Tracy Mahvan, PharmD, MBA, BCGP

Latest:

Managing COVID-19 at Home: A Toolbox

Helpful patient education suggestions for the successful management of COVID-19 at home and when it is appropriate to seek medical attention.


Amanda Warren

Latest:

Patients with ADHD May Share Medication

Many patients with ADHD report peers seeking nonmedical prescription stimulant use.


Sheri Tokumaru, PharmD

Latest:

Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs

Total cost of care for patients whose glycated hemoglobin levels were


Ariel K. Hill, AB

Latest:

Web Exclusive: Pharmacist Glycemic Control Team Associated With Improved Perioperative Glycemic and Utilization Outcomes

Implementation of a pharmacist-led glycemic control team was associated with improved glycemic control and utilization outcomes in a population of noncritically ill surgical patients.


Shivam Patel, Pharm.D.

Latest:

Metoprolol Tartrate Use in Patients with Congestive Heart Failure and Atrial Fibrillation

Current recommendation of beta blockers in patient with HF include bisoprolol, carvediol, or metoprolol succinate. Metoprolol tartrate may provide better rate control with twice daily dosing.


Daniel T. Boggie, PharmD

Latest:

Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.


Caroline Howard, PharmD, BCACP, CPP

Latest:

Population Health Management

Pharmacists play a vital role in chronic disease management.


Heather Morel, BS, MBA

Latest:

REMS Standards

Why are REMS not standardized today? Our columnist offers insight into the problem and how to lead specialty pharmacy forward.


Emma Yasinski

Latest:

Belief in Treatment Can Affect Patient Response to Pain Therapy

Chronic pain patient may respond to endogenous opioids differently than healthy people.


Rebecca A. Falter, PharmD

Latest:

Lipid Management When Converting Fluvastatin to Pravastatin: Medication Use Evaluation

There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.


Guido Zanni, PhD

Latest:

What Drives People to Overeat

Many different triggers prompt overeating, cues clinicians might use to a dieter's advantage.


Anne D. Martens, RN

Latest:

Psoriatric Arthritis: An Overview

Early diagnosis is the key to successful management of psoriatic arthritis, and treatment of this inflammatory disease is largely dependent on which symptoms are predominant.


Sarah N. Langford, PharmD candidate

Latest:

Nevada Addresses Costs for Diabetes Supplies

Manufacturers file challenge in court resulting in compromise between state government and pharmaceutical companies.



Amelia L. Persico MBA, PharmD

Latest:

Be Mindful of DDIs Between Analgesics and Oral Cancer Drugs

Although these chemotherapy agents provide convenience and ease, they are subject to hepatic first-pass metabolism and enzymatic drug-drug interactions.


Carisa D. Brewster

Latest:

Antacid Use During Pregnancy May Lead to Childhood Asthma

Up to 80% of women experience gastro-esophageal reflux disease during pregnancy.


Robert Kaminsky, MBA

Latest:

Hemophilia and Managed Care: Partnering to Achieve Cost-Effective Care

Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.


Adriana Molodecki, PharmD Candidate

Latest:

Teaching Concentrations Add Value to Colleges of Pharmacy

Does your pharmacy institution offer students the opportunity to earn a concentration alongside their PharmD degree?


Rebecca Shanahan, Kelly Ratliff

Latest:

The Pharmaceutical Ecosystem Must Work Together to Provide Sustainable Innovation and Ensure Patient Access

Growth in the use of specialty drugs demands the evolution of patient care models that leverage the knowledge of all relevant stakeholders. 


James Radke, Rare Disease Report

Latest:

Famed Writer Dying of Liver Cancer

Writer and neurologist Oliver Sacks confirms he has terminal cancer of the liver.


Arthur L. Allen, PharmD

Latest:

Potentially Inappropriate Prescribing of Direct-acting Oral Anticoagulants in the Veterans Health Administration

This study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.


Darcy Malard Johnson, PharmD

Latest:

Oncology Service Lines Prepare Pharmacy for Shift in Cancer Care Delivery

What can health systems do to provide a seamless journey during a time of uncertainty?


Chris Booth, PharmD

Latest:

Prevent Diversion During Drug Disposal

Building a team to support best practices, medication safety, and staff education will reduce risks.


Amish Patel

Latest:

Hemophilia Advancements and the Evolution of Patient Management

The coordinated-care models and high-touch services provided by specialty pharmacies put them in an ideal position to support patients with hemophilia now and in the future.


Alberto Coustasse, DRPh, MD, MBS, MPh

Latest:

503B: What Should Pharmacists Know for 2023?

When considering outsourcing, pharmacies should use a multistakeholder team to weigh pros and cons.


Nick C. Patel, PharmD, PhD, BCPP

Latest:

Understanding Predictors of Opioid Abuse: Predictive Model Development and Validation

This study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.